Director/PDMR Shareholding

RNS Number : 8795R

GlaxoSmithKline PLC

01 July 2015

 

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons

I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares ('ADSs') of GlaxoSmithKline plc ('Company').

On 30 June 2015, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £13.45 per Ordinary Share, and notional ADSs at a price of $42.20 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2015 to 30 June 2015:

Non Executive Director	Ordinary Shares	No. of ADSs
Sir Philip Hampton	2,730.912
Professor Sir Roy Anderson	673.792
Dr Stephanie Burns		539.199
Stacey Cartwright	534.387
Lynn  Elsenhans		1,070.720
Judy Lewent		457.147
Sir Deryck Maughan		1,359.719
Dr Daniel Podolsky		1,019.789
Urs Rohner	589.536
Hans Wijers	534.387

The Company and the Non-Executive Directors were informed of these allocations on 1 July 2015.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

1 July 2015

 

END

 

 

RDSLFLFBEDFEBBL